Alexion To Buy Synageva For $8.4B In Latest Big Pharma Deal
Alexion Pharmaceuticals Inc. has agreed to buy fellow drugmaker Synageva BioPharma Corp. for about $8.4 billion, the companies revealed Wednesday morning, marking the latest in what has been a wild wave...To view the full article, register now.
Already a subscriber? Click here to view full article